HIGH-TITER HIV-1 NEUTRALIZING ANTIBODY-RESPONSE OF RHESUS MACAQUES TO GP160 AND ENV PEPTIDES

被引:10
作者
RONCO, J
DEDIEU, JF
MARIE, FN
PINTER, A
KACZOREK, M
GIRARD, M
机构
[1] INST PASTEUR,DEPT VIROL,MOLEC VIROL LAB,CNRS,URA 545,28 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE
[2] PASTEUR MERIEUX SERUMS & VACCINS,PARC IND INCARVILLE,F-27101 VAL DE REUIL,FRANCE
[3] PROTEINE PERFORMANCE,F-75018 PARIS,FRANCE
[4] PUBL HLTH RES INST CITY NEW YORK INC,NEW YORK,NY 10016
关键词
D O I
10.1089/aid.1992.8.1117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Three groups of four rhesus macaques were immunized twice, one month apart with purified recombinant HIV-1LAI gp160 in the presence of either alum, incomplete Freund's adjuvant (IFA), or SAF-1. Two months later, the animals were injected twice again with a synthetic peptide with the sequence of the principal neutralization determinant (PND) of the HIV-1LAI isolate mixed with the same adjuvants. All animals received a booster injection of gp160 and PND peptide at 6 months. This regimen of immunization induced in the SAF-1 and IFA groups a high-titer neutralizing antibody response that declined progressively over the course of the following 6 months. In contrast, only a weak response was observed in the alum group. Neutralizing antibody titers varied as anti-PND titers, suggesting that they were principally targeted to the PND. A shortened immunization protocol comprising two injections of gp160 at 0 and 1 month followed by one injection of PND peptide at 3 months is suggested as optimal for the induction of high titers of HIV-1 neutralizing antibodies in primates.
引用
收藏
页码:1117 / 1123
页数:7
相关论文
共 44 条
[31]  
PUTNEY S D, 1990, AIDS (London), V4, pS129
[32]   HTLV-III/LAV - NEUTRALIZING ANTIBODIES TO AN ESCHERICHIA-COLI - PRODUCED FRAGMENT OF THE VIRUS ENVELOPE [J].
PUTNEY, SD ;
MATTHEWS, TJ ;
ROBEY, WG ;
LYNN, DL ;
ROBERTGUROFF, M ;
MUELLER, WT ;
LANGLOIS, AJ ;
GHRAYEB, J ;
PETTEWAY, SR ;
WEINHOLD, KJ ;
FISCHINGER, PJ ;
WONGSTAAL, F ;
GALLO, RC ;
BOLOGNESI, DP .
SCIENCE, 1986, 234 (4782) :1392-1395
[33]  
ROBINSON NE, 1990, AIDS S1, V4, pS151
[34]  
RONCO J, 1991, VACCINES 91, P29
[35]   PHOSPHOLIPIDS ENHANCE THE BINDING OF PEPTIDES TO CLASS-II MAJOR HISTOCOMPATIBILITY MOLECULES [J].
ROOF, RW ;
LUESCHER, IF ;
UNANUE, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1735-1739
[36]   ANTIBODIES THAT INHIBIT FUSION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS BIND A 24-AMINO ACID SEQUENCE OF THE VIRAL ENVELOPE, GP120 [J].
RUSCHE, JR ;
JAVAHERIAN, K ;
MCDANAL, C ;
PETRO, J ;
LYNN, DL ;
GRIMAILA, R ;
LANGLOIS, A ;
GALLO, RC ;
ARTHUR, LO ;
FISCHINGER, PJ ;
BOLOGNESI, DP ;
PUTNEY, SD ;
MATTHEWS, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :3198-3202
[37]   PROSPECTS FOR THE CONTROL OF AIDS BY IMMUNIZING SEROPOSITIVE INDIVIDUALS [J].
SALK, J .
NATURE, 1987, 327 (6122) :473-476
[38]  
SCHMITT D, 1989, CR ACAD SCI III-VIE, V308, P269
[39]  
Steimer K S, 1991, Biotechnol Ther, V2, P63
[40]   GP160, THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, IS A DIMER OF 125-KILODALTON SUBUNITS STABILIZED THROUGH INTERACTIONS BETWEEN THEIR GP41 DOMAINS [J].
THOMAS, DJ ;
WALL, JS ;
HAINFELD, JF ;
KACZOREK, M ;
BOOY, FP ;
TRUS, BL ;
EISERLING, FA ;
STEVEN, AC .
JOURNAL OF VIROLOGY, 1991, 65 (07) :3797-3803